medigraphic.com

2009, Number 1

<< Back Next >>

Rev Hosp Jua Mex 2009; 76 (1)

Experiencia obtenida a lo largo de 16 años en el Hospital Juárez de México acerca de la endocarditis infecciosa

Pérez GJH, Castellanos CL

Language: Spanish
References: 45
Page: 10-22
PDF size: 401.12 Kb.


ABSTRACT

Objective. This study was designed to determinate the Experienced of the Hospital Juarez de Mexico in patients with infective endocarditis. Material and methods. We studied 38 patients in the period of May 1991 to May 2006, with diagnostic of infective endocarditis. The patients were studied by transthoracic and transesophageal echocardiography. Clinical echocardiographic and microbiologic data were entered in a data base. Results. The maxim prevalence was between the third and fourth decades of the life in 24 cases (63.1%). 71% was discharged for improvement and 23.6% for death. Conclusions. The present study demonstrates that adequate antimicrobial treatment is necessary to low mortality. Infective endocarditis is an evolving disease with a persistently high mortality and morbidity even in the modern era of advanced diagnostic imaging, improved antimicrobial chemotherapy, and potentially curative surgery.


REFERENCES

  1. Tornos MP, Almirante B, Soler J. Historia natural y pronóstico de la endocarditis infecciosa. Rev Esp Cardiol 1998; 51(Supl. 2): 40-3.

  2. Degano AS, Bino AL, Chung KJ. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1990; 264: 2919-22.

  3. Dajani AS, Taubert KA, Wilson W. Prevention of bacterial endocarditis: recommendations by the American Heat Association. JAMA 1997; 277: 1794-801.

  4. Van der Meer JTM, van Wijk W, Thomson J, Vanderbroucke JP, et al. Efficacy of antibiotic prophylaxis for prevention of native valve endocarditis. Lancet 1992; 339: 135-9.

  5. Dieter H, Follatl F, Oto A. Guía de la práctica clínica sobre prevención, diagnóstico y tratamiento de la endocarditis infecciosa. Sociedad Europea de Cardiología. Rev Esp Cardiol 2004; 57(10): 952-26.

  6. García MM, Gurgui FM. ¿Se debe realizar profilaxis? ¿Es realmente efectiva? Riesgo de endocarditis tras cirugía cardiaca. Rev Esp Cardiol 1998; 51: 44-50.

  7. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med 1998; 129: 761-9.

  8. Anguera I, Quaglio G, Miró JM, Pare C, Azqueta M, Marco F, et al. Aortocardiac fistulas complicating infective endocarditis. Am J Cardiol 2001; 87: 652-4.

  9. Moon MR, Miller DC, Moore KA, Oyer PE, Mitchell RS, Robbins RC, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001; 71: 1164-71.

  10. Vallés F, Anguita M, Perez F. Guías de práctica clínica de la Sociedad Española de Cardiología en endocarditis. Rev Esp Cardiol 2000; 53: 1384-96.

  11. Endocarditis infecciosa: grado de discordancia entre lo recomendado por las guías clínicas y lo realizado en la práctica. Rev Esp Cardiol 2002; 55: 793-800.

  12. Devereux RB, Frary CJ, Kramer-Fox R, Roverts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with and without a mitral regurgitant murmur. Am J Cardiol 1994; 74: 1024-9.

  13. Endocarditis infecciosa: ¿tratamos correctamente a nuestros pacientes? Rev Esp Cardiol 2002; 55: 789-90.

  14. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98: 2936-48.

  15. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography), developed in collaboration with the American Society of Echocardiography. Circulation 1997; 95: 1686-744.

  16. Shively BK, Gurule FT, Roldán CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991; 18: 391-7.

  17. Vuille C, Nidorf M, Weyman AE, Picard MH. Natural history of vegetations during successful medical treatment of endocarditis. Am Heart J 1994; 128: 1200-9.

  18. Daniel WG, Mugge A, Martín RP, Lindert O, Hausmann D, Nonnast-Daniel B, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324: 795-800.

  19. Sochowski RA, Chan KL. Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. J Am Coll Cardiol 1993; 21: 216-21.

  20. San Román JA, Vilacosta I, Zamorano JL, Almería C, Sánchez- Harguindey L. Transesophageal echocardiography in right side endocarditis. J Am Coll Cardiol 1993; 21: 1226-30.

  21. Vilacosta I, Sarriá C, San Román JA, Jiménez J, Castillo JA, Iturralde E, et al. Usefulness of transesophageal endocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994; 89: 2684-7.

  22. Bayer AS. Infective endocarditis. Clin Infect Dis 1993; 17: 313-20.

  23. Von Reyn CF, Levy BS, Arbeit RD, Friedland GM, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981; 94: 505-18.

  24. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilisation of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200-9.

  25. Dodds GA, Sexton DJ, Durack DT, Bushore TM, Corey GR, Kisslo J. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 1996; 77: 403-7.

  26. Hoen B, Beguinot I, Rabaud C, Jaussaud R, Selton-Suty C, May T, et al. The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever of unknown origin. Clin Infect Dis 1996; 23: 298-302.

  27. Fournier PE, Casalta JP, Habib G, Messana T, Ralult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med 1996; 100: 629-33.

  28. Vivancos R, Barakat S, Álvarez J, Sánchez-Calle JM, Delgado JL, Rubio A, et al. Criterios diagnósticos de endocarditis infecciosa de Von Reyn a Duke. Ecocardiografía transtorácica y transesofágica. Rev Esp Cardiol 1998; 51(Supl. 2): 29-38.

  29. Bouza SE, Montero AA, Tornos MP. Profilaxis y manejo del paciente con endocarditis infecciosa. En: Normas de actuación clínica en cardiología. Madrid: Sociedad Española de Cardiología; 1996, p. 89-98.

  30. ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998; 32: 1486-588.

  31. Linares MP, Castro BA. Tratamiento de la endocarditis infecciosa sobre válvula nativa en pacientes no adictos a drogas por vía parenteral. Rev Esp Cardiol 1998; 51(Supl. 2): 51-57.

  32. Almirante GB, Tornos MP. Endocarditis protésica. Rev Esp Cardiol 1998; 51(Supl. 2): 58-63.

  33. Pascual A, Perea JP. El control del laboratorio en el diagnóstico y tratamiento de la endocarditis infecciosa. Rev Esp Cardiol 1998; 51(Supl. 2): 22-8.

  34. Karchmer AW. Infective endocarditis. En: Braunwald E (ed.). Heart disease a text book of cardiovascular medicine. Filadelfia: WB Saunders Company; 1997, p. 1077-105.

  35. Menesalvas A, Bouza E. Endocarditis infecciosa por microorganismos poco frecuentes. Rev Esp Cardiol 1998; 51(Supl. 2): 79-86.

  36. Moon MR, Stinson EB, Miller D. Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997; 40: 239-64.

  37. Acar C, Tolan M, Berrebi A, Gaer J, Gouezo R, Marchix T, et al. Homograft replacement of the mitral valve: graft selection, technique of implantation and results of forty-three patients. J Thorac Cardiovasc Surg 1996; 111: 367-78.

  38. Bauernschmitt R, Jakob HG, Vahl CH, Lange R, Hagl S. Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg 1998; 65: 359-64.

  39. Hendren WG, Morris AS, Rosenkranz ER. Mitral valve repair for bacterial endocarditis. J Thorac Cardiovasc Surg 1992; 103: 124-8.

  40. Lyttle BW, Priest PB, Taylor PC. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1996; 111: 198-207.

  41. Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J 1995; 16(Suppl. B): 84-9.

  42. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infec Dis 1998; 26: 1302-9.

  43. Jault F, Gandjbakhch I, Chastre JC, Levasseur JP, Bors V, Gibert C, et al. Prosthetic valve endocarditis with ring abscesses: surgical management and long term results. J Thorac Cardiovasc Surg 1993; 105: 1106-13.

  44. Guerra JM, Tornos MP, Permanyer-Miranda G, Almirante B, et al. Long term results of mechanical prostheses for treatment of active infective endocarditis. Heart 2001; 86: 63-8.

  45. Predictores de mortalidad hospitalaria en 186 episodios de endocarditis infecciosa activa en un centro de tercer nivel (1992-2001). Rev Esp Cardiol 2003; 56: 578-85.




2020     |     www.medigraphic.com